Cite
HARVARD Citation
Mollica, V. et al. (2020). Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors. Expert review of anticancer therapy. 20 (9), pp. 755-763. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mollica, V. et al. (2020). Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors. Expert review of anticancer therapy. 20 (9), pp. 755-763. [Online].